Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.

Something unusual happened on The View on Thursday: the table of hosts found themselves in agreement with Elon Musk.

Serena Williams has been turning heads with her recent slimmed-down appearance, prompting fans to speculate about her postpartum weight-loss journey. The 43-year-old tennis legend, who retired from ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...

At a 90-day postoperative follow-up, the study found that patients who used GLP-1s had significantly increased rates of deep vein thrombosis (1.6% vs. 0.9%), myocardial infarctions (1.6% vs. 0.9%), ...

We know that the popular weight-loss drug Ozempic can help people shed significant weight, but as the number of users ...

Whoopi Goldberg has a bone to pick with Robert F. Kennedy Jr., who thinks weight loss should come from diet and exercise instead of medications. On this morning’s episode of The View, Goldberg fired ...

Novo Nordisk announced on Thursday that a key European Medicines Agency committee has backed a label update for weight-loss ...

Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and ...

Thursday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has supported label update for weight-loss drug Ozempic to include kidney disease risk ...

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...